These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 12414862)

  • 21. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
    Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
    Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK; Pedersen SB; Fisker S; Richelsen B
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
    Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Heintze U; Janke J; Luft FC; Sharma AM
    Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.
    Moore JS; Monson JP; Kaltsas G; Putignano P; Wood PJ; Sheppard MC; Besser GM; Taylor NF; Stewart PM
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4172-7. PubMed ID: 10566668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells.
    Bujalska IJ; Walker EA; Hewison M; Stewart PM
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1205-10. PubMed ID: 11889189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation.
    Cooper MS; Bujalska I; Rabbitt E; Walker EA; Bland R; Sheppard MC; Hewison M; Stewart PM
    J Bone Miner Res; 2001 Jun; 16(6):1037-44. PubMed ID: 11393780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depot-specific messenger RNA expression of 11 beta-hydroxysteroid dehydrogenase type 1 and leptin in adipose tissue of children and adults.
    Li X; Lindquist S; Chen R; Myrnäs T; Angsten G; Olsson T; Hernell O
    Int J Obes (Lond); 2007 May; 31(5):820-8. PubMed ID: 17060929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary cortisol to cortisone metabolites in hypertensive obese children.
    Csábi GY; Juricskay S; Molnár D
    J Endocrinol Invest; 2000; 23(7):435-9. PubMed ID: 11005267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue.
    Veilleux A; Laberge PY; Morency J; Noël S; Luu-The V; Tchernof A
    J Steroid Biochem Mol Biol; 2010 Oct; 122(1-3):28-34. PubMed ID: 20206259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.
    Valsamakis G; Anwar A; Tomlinson JW; Shackleton CH; McTernan PG; Chetty R; Wood PJ; Banerjee AK; Holder G; Barnett AH; Stewart PM; Kumar S
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4755-61. PubMed ID: 15356090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel promoter for the 11beta-hydroxysteroid dehydrogenase type 1 gene is active in lung and is C/EBPalpha independent.
    Bruley C; Lyons V; Worsley AG; Wilde MD; Darlington GD; Morton NM; Seckl JR; Chapman KE
    Endocrinology; 2006 Jun; 147(6):2879-85. PubMed ID: 16543369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis.
    Tomlinson JW; Sherlock M; Hughes B; Hughes SV; Kilvington F; Bartlett W; Courtney R; Rejto P; Carley W; Stewart PM
    J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortisol metabolism after weight loss: associations with 11 β-HSD type 1 and markers of obesity in women.
    Rask E; Simonyte K; Lönn L; Axelson M
    Clin Endocrinol (Oxf); 2013 May; 78(5):700-5. PubMed ID: 22233384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats.
    Drake AJ; Livingstone DE; Andrew R; Seckl JR; Morton NM; Walker BR
    Endocrinology; 2005 Feb; 146(2):913-9. PubMed ID: 15550507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD; Azevedo I; Monteiro R; Martins MJ
    Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.
    Nair S; Lee YH; Lindsay RS; Walker BR; Tataranni PA; Bogardus C; Baier LJ; Permana PA
    Diabetologia; 2004 Jun; 47(6):1088-95. PubMed ID: 15156315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity.
    Wake DJ; Strand M; Rask E; Westerbacka J; Livingstone DE; Soderberg S; Andrew R; Yki-Jarvinen H; Olsson T; Walker BR
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):440-6. PubMed ID: 17302881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE; Walker BR
    J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.